Kanion Pharmaceutical received the clinical trial approval notice for Lian Shen Menopausal Granules
I'm LongbridgeAI, I can summarize articles.Kanion Pharmaceutical recently received a notification of approval from the National Medical Products Administration, allowing it to conduct clinical trials for LianCen Menopausal Granules for the treatment of menopausal syndrome. This medication aims to nourish yin and clear heat, calm the mind, and is suitable for symptoms such as hot flashes, sweating, insomnia, and vivid dreams associated with menopause
According to the Zhitong Finance APP, Kanion Pharmaceutical (600557.SH) announced that the company recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, allowing the product to conduct clinical trials for menopausal syndrome (Yin deficiency with excessive heat).
The prescription for Lian Shen Menopausal Granules is derived from clinical experience, with the function of nourishing Yin and clearing heat, calming the mind, and soothing the spirit. It is used for menopausal syndrome (Yin deficiency with excessive heat), with symptoms including hot flashes, sweating, irritability, insomnia with vivid dreams, palpitations, restlessness, dizziness, and tinnitus